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SUMMARY.-Castrate female rats given weekly applications of DMBA to the
genital tract and treated additionally with growth hormone, insulin or alloxan
(to induce diabetes) are heavier and have more sarcomatous and epithelial
cervico-vaginal neoplasms than intact animals under the same experimental
conditions. Promotion of carcinogenesis and gain in body weight are indepen-
dent phenomena caused by castration in the medicated rats. Growth hormone
is most effective in enhancing body weight in all animals, but least as regards
tumour formation. It reduces the incidence of sarcomas in intacts, but raises
that ofepithelial neoplasms, and promotes both types ofneoplasms in castrates.
The highest incidence of cervico-vaginal epithelial and sarcomatous tumours
occurs in spayed diabetics.
Squamous celled epitheliomas of the vulva are not affected by castration or
additional medication, while basal celled neoplasms tend to be more frequent
in intacts than in castrates and particularly numerous in intact failed diabetics.
Vulval sarcomas are usually rare but are increased in numbers in diabetic
and in insulin treated intacts.
Granular myoblastomas of the cervico-vaginal tract occur in intacts only
and particularly in diabetics and those medicated with growth hormone or
insulin.
STIAKILATION of growth of the normal structures of the female genital tract
ofcastrate rats does not lead to increasedcarcinogenesis nor ispromotion oftumour
formation paralleled by growth of the normal tissues. Thus castration lowers the
rate of induction by carcinogenic hydrocarbons of cervico-vaginal sarcomas
(Glucksmann and Cherry, 1958) and additional continuous administration of
oestrogens fails to increase carcinogenesisthough it restores to normal the atrophic
condition ofthegenital tract (Glucksmann andCherry, 1968). Tumour formation
is enhanced in castrate rats by adrenalectomy, administration of cortisone, of
cholesterol, bypelvic or wholebody irradiation andby medicationwithL-thyroxine
or methylthiouracil (Cherry and Glucksmann, 1970) though the normal epithelium
and stroma remain atrophic. The influence ofthyroactive substances on carcino-
genesis is iiot correlated with their effect on gain in body weight and general metabolic effects. The present paper reports on the action of additional treat-
ments withgrowth hormone, insulin and alloxan-induced diabetes on the induction
ofneoplasms in the genital tract of intact and castrate female rats and its relation
to gain in bodyweight andgrowth ofthe normal structures. It also compares the747 CARCINOGENESIS IN GENITAL TRACT OF RATS
effects on the induction of two tumour types (epithelial and sarcomatous) at the
same site, and that of the same tumour types (squamous celledneoplasms) at two
different sites, i.e. the vulva and the cervico-vaginal tract. Any generalized
metabolic effects might be expected to affect similarly careinogenesis of all types
and sites and growth of the body and of normal structures.
Alloxan-induced diabetes has been reported to inhibit tumour induction in
rats and mice (Garvie, 1968; Rosen, Budnick, Solomon andNichol, 1961; Goranson
and Tilser, 1955; Jehl, Mayer and McKee, 1955; Goranson, Botham and Willms,
1954;Salzberg andGriffin, 1952) whileprolongedadministrationofgrowthhormone
has been found to accelerate or promote careinogenesis (Reuber, 1968; Takakura,
Yamada and Hollander, 1967; Moon, Simpson, Li and Evans, 1950a, b). These
effects apply only to a single type oftumour, i.e. carcinoma or sarcoma at a single
site. Goranson and Tilser (1955) report that diabetes inhibits less the growth of
subcutaneous than of intraperitoneal implants of two transplantable tumours
(Novikoff hepatoma and Walker 256 carcinoma), but tumour growth at the two
sites was notinvestigatedsimultaneously in the same animal.
MATERIALS AND METHODS
Hooded rats of the Lister strain, random bred within a closed colony since
1940 were used for the various experiments which were conducted concurrently. The animals were housed not more than 7 to a cage and given water and food
pellets of MRC-diet 86 ad libitum. Only those surviving for at least 100 days
were considered at risk and the number ofrats in the various treatment groups are
given in Table 1.
TABLEI.-Additional Treatments and Number of Animals at Risk
Intact Castrate
Additional treatment rats rats
None (C) 43 36
Insulin (I) 23 20
Alloxan (S) 26 20
Alloxan (N) 15 16
Growth hormone (G) 21 20
Bilateral ovariectomy was performed under ether anaesthesia on rats aged 4-6 weeks. Carcinogenic treatment with a 1% solution of 9,10-dimethyl-1,2- benzanthracene (DMBA, Koch Light Ltd.) was started whe intact and castrate
animals were 8-10 weeks old. The vagina was stretched open by dorsal flexion
ofthe tail; the solution was applied by means of a cotton wool swab mounted on a
thin wire rod and distributed through a rotatory motion over the cervix, vagina and introitus. This procedure was repeated at weekly intervals for the life span of the rats.
Protamine zinc insulin B.P. (40 units/ml., Burroughs Wellcome & Co.) was
injected intramuscularly on 5 consecutive days per week in a daily dose of 1-2
units per rat. The injections Were started 5 days before the, first application of
DMBA and continued throughout the experimental period. Diabetes was induced in rats fasting for 24 hours by a single intraperitoneal injection of a 6% solution intyrode ofAlloxan (B.D.H.) on the basis of 150 mg./kg. body weight; immediately afterwards each rat received 2 units of insulin i.m.
and for the subsequent 24 hours a I% solution of glucose was administered as748 C. P. CHERRY AND A. GLUCKSMANN
drinking water. Drops of urine from each rat were tested on Clinistix paper
(AmesCompany) 24 hours and 7 days after the alloxaninjection andsubsequently
at fortnightly intervals throughout life and finally at post mortem. Initially
26 intact and 20 castrate rats had glycosuria (S) which persisted continuously in
some andintermittently in others for the life span. Fifteen intact and 16 castrate
animalsgiven alloxan never gave a positive reaction for glycosuria (N) on testing
with Clinistix paper. DMBA painting of the genital tract was started 2 weeks
after the injection of alloxan.
Bovine growth hormone (kindly presented by Dr. A. E. Wilhelmi of Emory
University, Atlanta, Georgia, on behalfofthe Endocrinology Study Section ofthe
National Institutes ofHealth, Bethesda,U.S.A.) was administeredintramuscularly
on 5 consecutive days per week in a daily dose of I mg. per rat. The injections
were started 5 days before the first application of DMBA and continued for 21
weeks.
All rats in the 8experimental groups were marked andweighedindividually at
fortnightly intervals. They were examinedclinicaRy atweekly intervals and sick
animals or those with signs ofvaginal or vulval tumours were killed and apost-
mortem performed. The organs of the geDital tract from ovary to vulva and in
addition the following tissues were taken for histological examination: pituitary,
thyroid, thymus, lungs, liver, spleen, pancreas, kidneys, adrenals, intestine,
mesenteric, lumbar and inguinal nodes. The material was fixed in Zenker-acetic
or Bouin's fluid, dehydrated, embedded in paraffin and sectioned at 6 or 8 It
depending on the organ. The endocrine glands and, when necessary, the cervix
and vagina were sectioned serially. Sections were stained with haematoxylin-
eosin, Van Gieson, carmalum-orange G-aniline blue, Southgate's mucicarmine
or the periodic acid-Schifftechnique (PAS) after diastase digestion.
Calculation of Results
In individual animals papiRomas and carcinomas often coexisted at the same
site and the most advanced lesion was the criterion used in the classification of
tumourbearing rats. When animals had more than one distincttype ofneoplasm
they were recorded separately under sarcomas, squamous epitheliomas and basal
celled tumours.
For the age-specific induction rates the percentage of tumour bearing rats at
risk for consecutive 100-dayperiods wasplotted at the 50-day interval.
RESULTS
Effett of additional treatments with alloxan, insulin or growth hormone on body
weight, castrate status and relationofweightgain to tumour incidence
The averageweights oftreated intact and spayed animals areplotted from the
start ofthe experiment for a subsequent period of up to 44 weeks in Fig. 1 and 2.
Fig. I records those for animals treated with alloxan of which those marked
" S
"
are diabetic, while those marked
" N
" are not. Fig. 2 gives the data for animals
injected with growth hormone (G) or with insulin (1). In an treatment groups
the castrate rats are heavier than the intact animals. The greatest weight gain
occurs with the administration of growth hormone, the least in diabetics, while
insuhn treated and failed diabetics form an intermediate group with essentiaRy
similar increases. The behaviour is the same for intacts and castratesthough theCARCINOGENESIS IN GENITAL TRACT OF RATS 749
gain is always greater in spayed animals. In all rats there is a steep increase up
to at most 20 weeks andonly aslight onesubsequently. The initial increase does
not appear to vary with the starting weight.
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FIG. I.---Average body weight of groups of rats given a single injection of alloxan and weekly applications of DMBA to the genital tract. S = diabetics, N = failed diabetics.
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FIG. 2.-Average body weight of groups of rats treated with growth hormone (G) or insulin (1) and with weekly applications of DMBA to the genital tract.
The additional treatment does not influence the atrophic condition of the
cervico-vaginal tract ofspayed rats. The diameter ofthe uterine horns in intacts
measures 3-4 times as much as that iri castrates (Cherry and Glucksmann, 1970). The incidence of cervico-vaginal sarcomas (with standard error) is plotted
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against the average final weight of animals in Fig. 3. Castrate animals are
clearly both heavier and have more sarcomas than intacts treated inthe same way.
Weight as such, i.e. irrespective of castrate status, is not correlated with tumour
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Fie,. 3.-Percentage of rats with cervico-vaginal sarcomas (with standard errors) plotted
against their average body weight. Additional treatment with growth hormone (G), insulin
J) or alloxan (S
= diabetics, N = failed diabetics).
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FIG. 4.-Percentage of rats with cervico-vaginal papillomas plus carcinomas (with standard
errors) plotted against their average body weight. Additional treatment with growth hormone (G), insulin (I) or alloxan (S
= diabetics, N = failed diabetics).J..
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incidence: castrates treated withgrowthhormone, though the heaviest group have
a percentage of sarcomas ofthe same order as the very much hghter intacts given
alloxan, insulin or growth hormone. On the other hand, castrates given methyl-
thiouracil (Cherry and Glucksmann, 1970) reach hardly the level of weight of
intact diabetics (215 g. as compared with 222g.), but have as many sarcomas
(90% + 4-75) as the much heavier castrates treated with alloxan or insulin.
Sarcomas Treatment
Alloxan (S)
Alloxan (N)
Insulin (1)
Growth hormone (6)
Control (C)
I
100 50 50 100 0
Percent
FiG. 5.-Percentage of intact rats with cervico-vaginal neoplasms induced by weekly paintings with DMBA and additional medications.
Sarcomas Papillomas F.
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Control (C) n
100 50 50 100 0
Percent
FIG. 6.--Percentage of castrate rats with cervico-vaginal neoplasms induced by weekly paintings with DMBA and additional medications.
Castrate animals have more papillomas and carcinomas of the cervico-vaginal tract and are heavier than intacts (Fig. 4), but there is no correlation between
weight of animals and tumour incidence for the different treatment groups. There is no clear correlation between weight, castrate status and incidence of
basal or squamous celled vulval tumours.
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Carcinomas 0
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I
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Tumours of the cervico-vaginal tract
Sarcomas.-The types of tumours induced cover the same range as described
previously (Glucksmann and Cherry, 1970a) varying from cellular sarcomas,
fibrosarcomas, leiomyosarcomas, rhabdomyosarcomas, myxosarcomas, haeman-
giosarcomas to mixtures of the various components. There is no predominant
type of sarcoma associated with anytype ofadditional treatment. In addition to
sarcomas granular myoblastomas (Dunn and Green, 1963) with characteristic
PAS-positive granulation are induced in the cervico-vaginal tract of intact
animals only. None are found in 76 castrates, but 12 in 85 intacts similarly
treated, i.e. 4 in 23 animals given insulin, 4 in 26 diabetics and 4 in 21 on growth
hormone. Non-diabetic intacts treated with alloxan have failed to produce these
tumours. The incidence of granular myoblastomas in the intact group is far
greater than in other series of experimental rats. When they occur at all, they
do so only in intacts such as I in 25 perinatally oestrogenized rats painted with
DMBA) 2 in 24 rats given cortisone perinatally and 2 in 21 androgenized rats
treated subsequently with progesterone and painted with DMBA.
In intact animals growth hormone reduces significantly the incidence of sar-
comas (Fig. 5, Table 11) which does not deviate significantly from the control
value with the other treatments. In castrates all additional medications increase
TABLE, II.-Significant Differences in the Incidence ofCervico-vaginal Sarcomas
Intact rats Castrate rats
S N I G C S N I G C
s 0 s 0 + +
N 0 N 0 + +
I 0 I 0 + +
G 0 + G + + + 0 +
c + 0 c + + + + 0
significantly the percentage of sarcomas above the level in the controls (Fig. 6,
Table 11) and insulin and alloxan (in both the S and N groups) above that of
similarly treated intacts. The difference between intacts and castrates with
additional administration ofgrowth hormone is notsignificant.
Sarcogenesis is also greatly accelerated in castrates medicated with insulin,
alloxan and growth hormone (Fig. 7) and is faster than in treated or untreated
intacts quite apart from the castrates not additionally medicated. The age-
specific plot (Fig. 8) shows a difference of about 100 days between intacts and
additionally treated castrates. Diabetic animals whether intact or spayed,
show the greatest promotion and acceleration of sarcoma induction and those on
growth hormone the least.
Epithelial tumours.-The histogenesis of cervico-vaginal papillomas, micro-
carcinomas and carcinomas has been described previously (Glucksmann and
Cherry, 1970a). In the present series no mixed carcinomas with a squamous and
columnar-celled component have been encountered nor any basal-celled tumours.
The incidence of epithelial neoplasms elicited by DMBA painting of rats given
additional medication is shown for intacts in Fig. 5 and castrates in Fig. 6. In
intacts the only significant deviation from the control level occurs with growth
hormone which raises the percentage of papillomas (Fig. 5, Table 111). The
effect of growth hormone on the epithelial tumours is thus opposite to that on
sarcogenesis in the cervico-vaginal tract which is significantly reduced (Fig. 5,. -.1
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Table II). In castrates the percentage ofpapillomas and also of carcinomas (Fig.
6, Table 111) is significantly greater in additionally treated than control animals
except for the non-diabetics following alloxan medication. The induction of
epitheliomas is significantly faster and greater in diabetic and insulin-treated
castrates than intacts and the difference is of a similar order as that for sarcomas
TABLE III.-Signi cant Differences in the Incidence ofEpithelial
Cervico-vaginal Tumours
Intact rats Castrate rats
S N I G C S N I G C
s 0 8 0 + + +
N 0 N + 0
I 0 I 0 +
G 0 + G + 0 +
c + 0 c + + + 0
Castrate Rat
.Intact Rats 60
m
C.2
a- 40
m
0-
20
100 200
Days
300 400
Fie.. 7.-Cumulative incidence of cervico-vaginal sarcomas in rats treated
weekly DMBA-paintings with growth hormone (G), insulin (I) or alloxan
N = failed diabetics).
in addition to
(S
= diabetics,
(Fig. 7 and 8). Castration does not affect materially the formation ofepithelial cervico-vaginal neoplasms in non-diabetics and those given growth hormone.
Tumours of the vulva
Thehistogenesis ofvulval tumours has been describedpreviously (Glucksmann andCherry, 1970b and 1971) and it has beenpointed out that most ofthe tumours
are epithelial arising in the epidermis or the hair folheles and sebaceous glands.754 C. P. CHERRY AND A. GLUCKSMANN
The induction of squamous celled papillomas and their progress to malignancy is
not materially affected by additional treatments or by castration (Fig. 9 and 10).
Basal-celled tumours are consistently more frequent in intacts than castrates
(Fig. 9 and 10) and this applies also to carcinomas: in 85 intacts there are 32
tumours including 16 carcinomas and in 76 castrates the comparable figures are
21 and 9. Alloxan treated non-diabetics have significantly more basal-celled
neoplasms than diabetics or rats given growth hormone whether or not castrated.
80-
.I.-
w
2C..) 40-
w
CL.
0 250 450
Days
FIG. 8.-Age-specific incidence of cervico-vaginal sarcomas in rats treated in addition to
weekly DMBA-paintings with growth hormone (G), insulin J) or alloxan (S
= diabetics,
N = failed diabetics).
Only the intact non-diabetics have a significantly greater percentage of basal-
celled epitheliomas than intactsgiven insulin or no additional treatment while the
castrates ofthese groups do not differ significantly.
Sarcomas are induced less frequently in the vulva than in the dorsal skin by
painting with DMBA and at the latter site castration reduces their incidence
(Glucksmann and Cherry, 1971). With various additional treatment schedules
excluding those described in the present paper, 4 sarcomas have been elicited in
the vulva of 357 intact and in only I of 560 castrate animals similarly treated.
In the present series 5 sarcomas are present in the vulva of 85 intacts and 1 inI i m
rIm
i I
L
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76 castrates, i.e. 3 in intact diabetics and 2 in intacts on insulin and I in a castrate
non-diabetic. In addition fibromas appear in 4 intact animals (2 non-diabetics,
I each on insulin and growth hormone). The difference in the percentage of
benign and malignant connective tissue tumours in intacts (II%) and that in
Squamous Celled Basal Celled - - --
Treatment
Alloxan (S)
Carcinomas Papillomas Papillomas El
Carcinomas 0
Alloxan (N)
A I ILI I
Insulin (1)
Growth hormone(G)
Control (C)
100 50 50 100
Percent
FIG. 9.-Percentage of intact rats with vulval tumours induced by weekly DMBA applications and additional treatments.
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Control (C)
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E'IG. IO.-Percentage of castrate rats with vulval tumours induced by weekly DMBA applications and additional treatments.
castrates (I%) is significant (10 + 3-6). There is also an approximately 10-fold
increase in the incidence ofvulval sarcomas in intact and castrate ratsadditionally treated with alloxan, insulin or growth hormone compared with no or with other
additional treatments. In intacts no other medication has equalled the yield of 9% and 12% ofvulva] sarcomas in diabetic rats or thosegiven insulin.756 C. P. CHERRY AND A. GLUCKSMANN
DISCUSSION
Gain in body weight and incidence of sarcomas and epithelial tumours of the
cervico-vaginal tract is considerably greater in spayed than in similarly treated
intact rats. There is, however, no correlation between weight and carcinogenesis
if different treatments are compared: diabetics are not asheavy as animals treated
withgrowthhormone, but have ahigherincidence ofneoplasms and the same holds
true for those treated with methylthiouracil and L-thyroxine (Cherry and
Glucksmann, 1970). Castration rather than increase inweight is significant in the
promotion ofDMBA-induced tumours by additional treatments and isresponsible
for these two independent phenomena.
The increase in sarcomas of castratesgiven insulin, alloxan orgrowth hormone
exceeds notonlythecontrols, but also thesimilarlytreatedintact rats inbothspeed
of formation and percentage. The same relation obtains for epithelial tumours
of the cervico-vaginal tract where the differences between intacts and castrates
treated with insulin or rendered diabetic with alloxan are highly significant.
Similar ratios are seen in rats exposed to only 5, 10 or 20 weekly administrations
of DMBA (Glucksmann and Cherry, 1970a). With 40 weekly paintings only
insulin treatment and diabetes maintain this high level of tumours, while even
medication with methylthiouracil or L-thyroxine fail to do so.
The rather rare granular myoblastomas are found in intact animals only,
particularly after administration of insulin or growth hormone and in diabetics
though not in rats refractory to alloxan-induced diabetes. Similarly sarcomas
and fibromas of the vulva are rare as compared with the dorsal skin (Glucksmann
and Cherry, 1971), but occur more often in intact than spayed animals. Basal-
celled vulval tumours tend to beslightly morefrequent in intacts than in castrates.
They are increased very significantly in failed diabeticsparticularly in intacts and
suppressed in 'chstrates, given methvlthiouracil (Glucksmann and Cherry, 1970b).
The percentage of induced squamous-celled tumours of the vulva is not greatly
influenced by castration or additional medications, but is reduced if the weekly
applications are limited to 5 or 10.
Weekly applications of DMBA for life elicit a high percentage of cervico-
vaginal sarcomas in intacts, a low one in castrates and an even lower one ofepithe-
lial tumours at this site in all animals. It is thus not difficult to reduce formation
of connective tissue tumours in intacts and promote them in castrates rather than
produce the opposite effects. For the same reason epithelial tumours can be
increased rather than reduced. Five groups of additional treatments have been
tried to find an adequate explanation for the effect of castration on the induction
of sarcomas and the failure ofoestrogens to compensate for it:
(1) Procedures affecting the target tissues: oestrogens in various regimes,
progesterone, pregnancy, testosterone, adrenalectomy in castrates (to remove
residual steroid production), cholesterol as control for oestradiol pellets in
cholesterol;
(2) Reduction of immunological competence: cortisone, pelvic and whole
body X-irradiation;
(3) General and specific metabolic changes: L-thyroxine, methylthiouracil,
growth hormone, insulin and diabetes;
(4) Effect on regulatory centres by perinatal treatments with testosterone,
oestrogens, cortisone, L-thyroxine and methylthiouracil;CARCINOGENESIS IN GENITAL TRACT OF RATS 757
(5) Variation in carcinogenic dosage by reducing the number ofweekly doses
of DMBA to 5, 10 or 20 and in castrates additional medication with L-thyroxine
ormethylthiouracil.
The effects of the various treatments on carcinogenesis in the cervico-vaginal
tract of intacts and castrates are summarized in Table IV in comparison with
those ofweekly doses of DMBA given for life and no additional treatment of the
animals. The total number ofdifferent additionalprocedures is 26 for intacts and
29 for castrates. It is quite evident that castrates and intacts are affected differ-
ently by the same treatments and that in either group of animals the stimulating effects ofadditional treatments on sarcomaformation may not beequalledby those
on epithelial tumours.
TABLE IV.-Changes in the Incidence ofCervico-vaginal Tumours
Sarcomas Epitheliomas Treatments
Up Up none
X-rays: pelvic and whole body; cortisone; cholesterol; intermittent stilboestrol; testosterone;
methylthiouracil + stilboestrol;growthhormone; insulin; diabetes
Up Equal none
adrenalectomy;progesterone + oestrogen; testosterone + stilboestrol; L-thyroxine ± stilboestrol; non-diabetics
Down Equal oestrogens; 5, 10 or 20 x DMBA; X-rays: pelvic and
whole body; methylthiouracil + L-thyroxine; perinatal treatments with: testosterone, L-thyroxine, methylthiouracil, cortisone
none
Down Up progesterone; growth hormone; perinatal treatment
with oestrogen
5 and 10 x DMBA ± L-thyroxine or methylthiouracil
Equal UP methylthiouracil ± stilboestrol
methylthiouracil + L-thyroxine; 20 x DMBA ± L-
thyroxine or methylthiouracil
Equal Equal testosterone ± stilboestrol; pregnancy; intermittent
stilboestrol; L-thyroxine ± stilboestrol; cortisone; insulin; diabetes; non-diabetics
oestrogens; progesterone
In intactsgrowth hormone reduces the incidence of sarcomas but increases that of epithelial tumours, while in castrates the rate of formation of both types of
tumoursisenhanced andaccelerated. Pelvic orwholebodyX-irradiationsterilizes intacts and inhibits careinogenesis while it promotes it in castrates. In spayed animals the induction of sarcomas is promoted by 17 of the 29 procedures listed in Table IV and reduced only by lower dosage of DMBA, while none of the 26 additional treatments applied to intacts promotes and II inhibit the formation of
sarcomas. The rate of sarcogenesis in intacts is not maximal as shown by com- parison with castrates medicated with insulin or alloxan (Fig. 7). Similarly epithelial tumours occur more frequently in castrates with 21 ofthe 29 additional treatments and only with 4 in intacts. Squamous-celled neoplasms of the vulva
are affected only by carcinogenic dosage and not by any of the other additional procedures, while basal-celled tumours at the same site are influenced by agents affecting the growth ofthe hair follicles.758 C. P. CHERRY AND A. GLUCKSMANN
It remains rather puzzling that castration due to surgery or irradiation ea-uses
both atrophy of the cervico-vaginal tract and an inhibition of carcinogenesis,
that compensatory growth of the normal structures of the same site elicited by
effective doses of oestrogens is not accompanied by an increase in tumour induc-
tion, while a variety of other treatments without compensating for the atrophy
of the cervico-vaginal tract and irrespective of their effect on gain in body weight
promote careinogenesis in castrates rather than in intacts to a rate exceeding that
of intact animals without or with additional treatments. The metabolic changes
induced by medication with growth hormone, insulin or alloxan like those with
thyroactivecompounds affectdifferently the formation ofthe same tumou-rtype at
different sites, development of different tumour types at the same location and
gain inbody weight in intact and castrate rats.
This work was supportedbygrants from the CancerCampaign for Research.
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